Market Overview

From Earlier: Sagent Pharmaceuticals Reports Q3 EPS $-0.13 vs $-0.20 Est; Revenues $49.4M vs $48.60M Est

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Earnings News

 

Related Articles (SGNT)

Around the Web, We're Loving...

Get Benzinga's Newsletters